These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35930049)

  • 1. The clinical relevance of native vitamin D in pediatric kidney disease.
    Banerjee S; Sengupta J; Basu S
    Pediatr Nephrol; 2023 Apr; 38(4):945-955. PubMed ID: 35930049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world assessment: effectiveness and safety of extended-release calcifediol and other vitamin D therapies for secondary hyperparathyroidism in CKD patients.
    Germain MJ; Paul SK; Fadda G; Broumand V; Nguyen A; McGarvey NH; Gitlin MD; Bishop CW; Csomor P; Strugnell S; Ashfaq A
    BMC Nephrol; 2022 Nov; 23(1):362. PubMed ID: 36368937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional vitamin D use in chronic kidney disease: a survey of pediatric nephrologists.
    Griffin LM; Denburg MR; Shults J; Furth SL; Salusky IB; Hwang W; Leonard MB
    Pediatr Nephrol; 2013 Feb; 28(2):265-75. PubMed ID: 23086591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of renal function on vitamin D metabolism in the very elderly.
    Van Pottelbergh G; Matheï C; Vaes B; Adriaensen W; Gruson D; Degryse JM
    J Nutr Health Aging; 2013 Feb; 17(2):107-11. PubMed ID: 23364486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended-release calcifediol in stage 3-4 chronic kidney disease: a new therapy for the treatment of secondary hyperparathyroidism associated with hypovitaminosis D.
    Cozzolino M; Minghetti P; Navarra P
    J Nephrol; 2022 Apr; 35(3):863-873. PubMed ID: 34626363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of vitamin D in relation to bone health.
    Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
    Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease.
    Agarwal R; Georgianos PI
    Nephrol Dial Transplant; 2016 May; 31(5):706-13. PubMed ID: 27190392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can Stoss Therapy Be Used in Children with Vitamin D Deficiency or Insufficiency without Rickets?
    Koçyiğit C; Çatlı G; İnce G; Özkan EB; Dündar BN
    J Clin Res Pediatr Endocrinol; 2017 Jun; 9(2):150-155. PubMed ID: 28077342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Effects of Vitamin D Status, Renal Function and Age on Serum Parathyroid Hormone Levels.
    Niculescu DA; Deacu LG; Caragheorgheopol A; Popescu N; Ghemigian A; Procopiuc C; Rosca R; Poiana C
    Front Endocrinol (Lausanne); 2021; 12():657991. PubMed ID: 33995282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypovitaminosis D Is Prevalent in Patients With Renal AL Amyloidosis and Associated With Renal Outcome.
    Muchtar E; Drake MT; Leung N; Dispenzieri A; Lacy MQ; Buadi FK; Dingli D; Hayman SR; Kapoor P; Hwa YL; Fonder A; Hobbs M; Gonsalves W; Kourelis TV; Warsame R; Russell S; Go RS; Binder M; Kyle RA; Rajkumar SV; Kumar SK; Gertz MA
    Front Endocrinol (Lausanne); 2022; 13():891712. PubMed ID: 35800433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecalciferol (vitamin D3) therapy and vitamin D insufficiency in patients with chronic kidney disease: a randomized controlled pilot study.
    Chandra P; Binongo JN; Ziegler TR; Schlanger LE; Wang W; Someren JT; Tangpricha V
    Endocr Pract; 2008; 14(1):10-7. PubMed ID: 18238736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cholecalciferol for lowering albuminuria in chronic kidney disease: a prospective controlled study.
    Molina P; Górriz JL; Molina MD; Peris A; Beltrán S; Kanter J; Escudero V; Romero R; Pallardó LM
    Nephrol Dial Transplant; 2014 Jan; 29(1):97-109. PubMed ID: 23975842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D deficiency in chronic kidney disease: Myth or reality?
    Priyadarshini G; Parameswaran S; Sahoo J; Selvarajan S; Rajappa M
    Clin Chim Acta; 2021 Dec; 523():35-37. PubMed ID: 34480954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D in Chronic Kidney Disease and Dialysis Patients.
    Jean G; Souberbielle JC; Chazot C
    Nutrients; 2017 Mar; 9(4):. PubMed ID: 28346348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum 25-hydroxyvitamin D deficiency; a risk factor for chronic kidney disease in ambulatory indigent patients.
    Kaptein EM; Yi SS; Endres DB; Kaptein JS; Chan LS
    Endocr Pract; 2014 Mar; 20(3):236-43. PubMed ID: 24246347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment.
    Joy MS; Karagiannis PC; Peyerl FW
    J Manag Care Pharm; 2007 Jun; 13(5):397-411. PubMed ID: 17605511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effect of Long-Term Cholecalciferol Supplementation on Vascular Calcification in Chronic Kidney Disease Patients With Hypovitaminosis D.
    Samaan F; Carvalho AB; Pillar R; Rocha LA; Cassiolato JL; Cuppari L; Canziani MEF
    J Ren Nutr; 2019 Sep; 29(5):407-415. PubMed ID: 30686750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
    Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
    J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pattern of 25-hydroxy vitamin D response at short (2 month) and long (1 year) interval after 8 weeks of oral supplementation with cholecalciferol in Asian Indians with chronic hypovitaminosis D.
    Goswami R; Gupta N; Ray D; Singh N; Tomar N
    Br J Nutr; 2008 Sep; 100(3):526-9. PubMed ID: 18252022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.